A reflection on the improvement of Chinese hamster ovary cell-based bioprocesses through advances in proteomic techniques.

Melanie Nguyen, Aline Zimmer

Biotechnology advances 2023 Jul-Aug

filter terms:

Chinese hamster ovary (CHO) cells are the preferred mammalian host for the large-scale production of recombinant proteins in the biopharmaceutical industry. Research endeavors have been directed to the optimization of CHO-based bioprocesses to increase protein quantity and quality, often in an empirical manner. To provide a rationale for those achievements, a myriad of CHO proteomic studies has arisen in recent decades. This review gives an overview of significant advances in LC-MS-based proteomics and sheds light on CHO proteomic studies, with a particular focus on CHO cells with superior bioprocessing phenotypes (growth, viability, titer, productivity and cQA), that have exploited novel proteomic or sub-omic techniques. These proteomic findings expand the current knowledge and understanding about the underlying protein clusters, protein regulatory networks and biological pathways governing such phenotypic changes. The proteomic studies, highlighted herein, will help in the targeted modulation of these cell factories to the desired needs. Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.

Citation

Melanie Nguyen, Aline Zimmer. A reflection on the improvement of Chinese hamster ovary cell-based bioprocesses through advances in proteomic techniques. Biotechnology advances. 2023 Jul-Aug;65:108141